Profhilo® Alternatives: How Do Bio-Remodelling Options Compare?
A Profhilo® alternative is any professional product that targets the same outcome — overall skin quality, hydration and elasticity rather than localised volume — through a different mechanism or format. The realistic options fall into four groups: other stabilised-HA skin boosters, collagen-stimulating boosters (PLLA- or CaHA-based), polynucleotide products, and the newest group, exosome serums delivered by mesotherapy or microneedling. None of them is a like-for-like copy; each trades differently on mechanism, protocol length, downtime and price per treatment course.
This comparison is written for clinics deciding what to stock, not for consumers. All third-party product characteristics cited below are based on manufacturer-published data; trademarks belong to their respective owners and are used nominatively, for identification only. Profhilo® is a registered trademark of the IBSA group ; Alva Medica is not affiliated with, endorsed by or connected to IBSA.
What does Profhilo® actually do — and what are clinics comparing against?
According to its manufacturer's published materials, Profhilo® is an injectable based on a high concentration of hyaluronic acid (64 mg in 2 ml, combining high- and low-molecular-weight HA) stabilised thermally into hybrid cooperative complexes rather than chemically cross-linked. The published protocol is short — typically two sessions, one month apart, using a small number of injection points per side of the face — and the positioning is "bio-remodelling": diffuse tissue improvement, not shape.
That gives clinics a concrete benchmark for any alternative: high total HA dose per session, a short two-visit protocol, minimal downtime, and a skin-quality (not volume) endpoint. The honest question is not "what is identical" but "which mechanism fits this patient and this menu".
Which product categories work as alternatives?
Stabilised-HA skin boosters
The closest mechanical relatives: injectable HA designed to hydrate and improve elasticity from within the dermis, typically over a 2–3-session series. The category, its science and its consultation rules are covered in our skin boosters guide. Differences against a bio-remodelling product are mostly protocol shape — more sessions, smaller depots — rather than endpoint.
Collagen-stimulating boosters (PLLA, CaHA)
Where the patient's real deficit is firmness and density rather than hydration, collagen-inducing boosters compete directly. ExoPrime PLLA+CMC NAD+ is a ready-to-use example from the MedRoyal portfolio we distribute: poly-L-lactic acid for gentle collagen stimulation carried in a lightly cross-linked CMC gel, with NAD+ and plant-derived exosomes, targeting visible improvement within 3–5 sessions without added volume. ExoPrime ExoCaha NAD+ does the same job with calcium hydroxyapatite as the collagen inducer, aimed at density on cheeks, jawline, neck and décolleté.
Polynucleotides (PN/PDRN)
Polynucleotides are the fastest-growing regenerative category in Europe by search demand, positioned on tissue repair and hydration. For clinics, PN products behave like a regenerative booster series; products combining PN with other stimulators (for example PLLA+PN preparations) blur into the biostimulator category — see our comparison of biostimulators vs fillers for where that line runs.
Exosome serums (mesotherapy / microneedling delivery)
Exosome serums are the portfolio's needle-free-option answer: applied with microneedling or mesotherapy technique rather than sold as injectables, which changes both the regulatory position and who in the team can deliver them. ExoPrime Exoglow Face NAD+ combines plant-derived exosomes (papaya and apple lines, produced antibiotic-free in a Class 100 cleanroom) with NAD+ for skin-quality series work. For a full landscape view, see our exosome serums comparison.
The lip zone specifically
Bio-remodelling demand increasingly includes the lip and perioral area, where classic volumising fillers are the wrong tool for hydration-first patients. Hyalivia Aqua Lips is the portfolio's answer there: a CE-marked lip formula pairing dual-molecular-weight hyaluronic acid with NAD+ (SIRT1 activation) and proline — lasting hydration, elasticity and natural volume rather than projection.
How do the options compare at a glance?
| Option | Primary mechanism | Typical protocol | Endpoint |
|---|---|---|---|
| Profhilo® (benchmark) | Thermally stabilised H-HA/L-HA complexes | 2 sessions, ~1 month apart (per manufacturer) | Diffuse skin quality, hydration |
| Stabilised-HA skin boosters | Slowly resorbing HA depots | 2–3 sessions + maintenance | Hydration, elasticity |
| ExoPrime PLLA+CMC NAD+ | PLLA collagen stimulation + CMC carrier | 3–5 sessions, 2–4-week intervals | Texture, firmness, radiance |
| ExoPrime ExoCaha NAD+ | CaHA collagen induction + amino acids | 3–5 sessions, 2–4-week intervals | Density, firmness, no volume |
| Polynucleotides (PN/PDRN) | DNA-fragment-driven tissue repair | Series, product-dependent | Regeneration, hydration |
| Exosome serums (ExoPrime range) | Exosome signalling + NAD+, transdermal delivery | Series with microneedling/meso technique | Skin quality, regeneration |
Protocol figures for MedRoyal products reflect the published product materials we distribute; always defer to the current IFU.
How should a clinic choose between them?
Choose on the patient's dominant deficit and your delivery model. Hydration-dominant, injectable-comfortable patients sit closest to the stabilised-HA benchmark. Laxity- and density-dominant patients get more from PLLA or CaHA collagen induction. Patients who refuse needles — or clinics whose staffing favours microneedling protocols — are the natural fit for exosome serums. Many clinics stock one option per mechanism rather than several rivals within one mechanism; that keeps the menu explainable and the training load sane.
Commercially, compare cost per completed course, not per vial: a two-session protocol at a higher unit price can beat a five-session series on chair time, and vice versa on retail price tolerance. As the official MedRoyal distributor, we quote per market and volume — add the products above to a quote request, or see our wholesale terms if you buy for a group or resale.
FAQ
Is there a direct generic equivalent of Profhilo®?
No. Its manufacturer describes a patented thermal stabilisation process, so alternatives differ by design — either in HA architecture, in mechanism (PLLA, CaHA, PN, exosomes) or in delivery route. The practical question for a clinic is which mechanism serves the same patient goal, not which product copies the formula.
Which alternative suits patients who decline injections?
Exosome serums delivered with microneedling are the strongest needle-free option in the skin-quality space. The ExoPrime range pairs plant-derived exosomes with NAD+ across face, PDRN, hair and peel variants, so a clinic can run regenerative series without an injectable consent conversation.
Can these alternatives be combined with fillers or biostimulators?
Yes — skin-quality products and volumising tools address different tissue problems and are routinely staged in one treatment plan. The sequencing logic (structure first or quality first) is covered in our biostimulators vs fillers comparison; product-level compatibility should always follow the IFU of each preparation.
Why does Alva Medica publish no prices for these products?
We sell B2B at terms that depend on volume, market and partnership level, so a public price would be wrong for almost every buyer. Add products to a quote request and you receive a quotation for your situation within one business day.
All third-party product information above is based on manufacturer-published data at the time of writing and is provided for professional comparison only. Trademarks remain the property of their respective owners; nominative use only, no affiliation or endorsement implied. Last updated: 2026-08-10.